Pharmaceuticals

Influenza Vaccines Market Report 2026: Strategic Insights and Revenue Outlook

February 16, 2026March 11, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the influenza vaccines market from 2026–2035 with trusted insights from The Business Research Company

What is the expected shift in the Influenza Vaccines Market’s size between 2026 and 2030?

The influenza vaccines market has experienced robust expansion in recent times. This market is projected to expand from $9.04 billion in 2025 to $9.71 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.4%. Historically, this growth was driven by factors such as the increasing prevalence of seasonal influenza, a limited public awareness during the early 2000s, the widespread use of trivalent vaccines, constrained global manufacturing capabilities, and a dependence on conventional egg-based production methods.

The influenza vaccines market size is expected to experience robust expansion in the coming years. It is forecast to achieve a valuation of $13.13 billion by 2030, advancing at a compound annual growth rate (CAGR) of 7.8%. This growth over the projection period is attributed to several factors, including the increasing uptake of quadrivalent vaccines, the broader application of precision medicine approaches, escalating government-led vaccination efforts, the progression of cell-based and recombinant vaccine development, and enhancements in cold chain and distribution infrastructure. Prominent trends for the forecast period include optimizing seasonal vaccine formulations, broadening pediatric immunization initiatives, an uptick in government-funded influenza vaccination campaigns, the integration of novel adjuvants for improved immunogenicity, and an increase in home-based and outpatient vaccine delivery methods.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11935&type=smp

Which Drivers Are Shaping Strategic Decisions In The Influenza Vaccines Market?

An anticipated increase in seasonal influenza cases is projected to drive the expansion of the influenza vaccine market moving ahead. Seasonal influenza is defined as a respiratory ailment stemming from influenza viruses, which commonly spread and lead to infections during particular periods annually, generally in cooler seasons. This trend has emerged due to antigenic drift, the vulnerability of populations, environmental influences, insufficient vaccine penetration, and the absence of widespread immunization. Influenza vaccinations contribute to lowering the occurrences of seasonal influenza by offering immunity against the currently circulating viral strains. For instance, in November 2023, the Centers for Disease Control and Prevention (CDC), a government body located in the US, disclosed that the 2022-2023 flu season saw roughly 31 million flu-related illnesses, 14 million flu-related medical visits, 360,000 flu-related hospitalizations, and 21,000 flu-related deaths. Consequently, the increasing frequency of influenza seasons is fueling the expansion of the influenza vaccines market.

What Segment Categories Are Covered In The Influenza Vaccines Market?

The influenza vaccines market covered in this report is segmented –

1) By Vaccine Type: Inactivated, Live Attenuated

2) By Valency: Quadrivalent, Trivalent

3) By Route Of Administration: Injection, Nasal Spray

4) By Age Group: Pediatric, Adult

5) By Distribution Channel: Hospitals And Pharmacies, Government And Institutional Supply, Other Distribution Channels

Subsegments:

1) By Inactivated: Trivalent Inactivated Vaccines (TIV), Quadrivalent Inactivated Vaccines (QIV)

2) By Live Attenuated: Live Attenuated Influenza Vaccines (LAIV), Quadrivalent Live Attenuated Influenza Vaccines (QLAIV)

What Industry Trends Are Transforming The Influenza Vaccines Market?

Leading companies in the influenza vaccine market are implementing advanced product innovations, such as quadrivalent seasonal influenza vaccines, to bolster their respiratory vaccine product lines and financial standing. A quadrivalent seasonal influenza vaccine is engineered to protect against four different flu viruses, specifically two influenza A viruses and two influenza B viruses. For example, in September 2023, Clover Biopharmaceuticals Ltd., a China-based biotechnology firm, introduced AdimFlu-S (QIS), a quadrivalent seasonal influenza vaccine. This vaccine represents the only imported quadrivalent seasonal influenza vaccine approved for individuals aged three years and older in China. The quadrivalent formulation of the vaccine enhances its potential to achieve high vaccine effectiveness, regardless of which influenza B strain becomes seasonally widespread, particularly when compared with trivalent varieties.

Which Key Players Are Driving Competition In The Influenza Vaccines Market?

Major companies operating in the influenza vaccines market are Pfizer Inc., Merck & Co Inc., Sanofi-Aventis LLC, GlaxoSmithKline plc, Serum Institute of India Private Limited, Seqirus Inc., CSL Limited, Daiichi Sankyo Company Limited, Moderna Inc., Novavax AB, Bharat Biotech International Limited, Valneva SE, Shionogi & Co Ltd., Sinovac Biotech Co Ltd., Walvax Biotechnology Co Ltd., Hualan Biological Engineering Inc., China National Pharmaceutical Group Corporation, Green Cross Corporation, Mitsubishi Tanabe Pharma Corporation, Osivax, Vaxess Technologies Inc., Gamma Vaccines Pty Ltd

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/influenza-vaccines-global-market-report

Which Region Is Projected To Lead The Influenza Vaccines Market During The Forecast Period?

North America was the largest region in the influenza vaccines market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the influenza vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Influenza Vaccines Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=11935&type=smp

Browse Through More Reports Similar to the Global Influenza Vaccines Market 2026, By The Business Research Company

Influenza Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/influenza-vaccines-global-market-report

Influenza Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/influenza-treatment-global-market-report

Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795